(June 17, 2016, 9:32 AM EDT) -- WASHINGTON, D.C. — Unlike Mayo Collaborative Services v. Prometheus Laboratories Inc. (566 U.S. __ 132 S. Ct. 1289 [2012]) where all the process steps were already used in the same combination claimed by the patent, Sequenom Inc. argues in a June 6 brief to the U.S. Supreme Court that inventors of a fetal DNA test patent used what they alone knew about the world to motivate a new combination of pre-existing techniques, “enabling revolutionary practical results” (Sequenom Inc. v. Ariosa Diagnostics Inc., et al., No. 15-1182, U.S. Sup.)....